meddevicedb.com FDA Device Reference

INDIRECT FLUORESCENCE ASSAY FOR ANTI-NUCLEAR ANTIBODIES IGG ANTIBODY

K990915 Class II Traditional
Decision Date
1999-04-21
Sponsor / Applicant
Stellar Bio Systems, Inc.

Technical Specification

510(k) Submission ID K990915
Product Code DHN
Medical Specialty / Panel Immunology
Regulation Citation 21 CFR 866.5100
Decision Date 1999-04-21
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

INDIRECT FLUORESCENCE ASSAY FOR ANTI-NUCLEAR ANTIBODIES IGG ANTIBODY received FDA 510(k) clearance under submission number K990915, sponsored by Stellar Bio Systems, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1999-04-21.

Classification & Regulation

This clearance is catalogued under FDA product code DHN and 21 CFR 866.5100, within the Immunology review panel as a Class II device.